SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma informs about allotment of non-convertible debentures

16 Oct 2024 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to its letter dated September 30, 2024, Mankind Pharma has informed that the Fund Raising Committee of the Directors of the Company vide circular resolution passed today i.e. October 16, 2024, has allotted the following Non-Convertible Debentures; 1. 125,000 INR denominated, listed, rated, secured, redeemable, transferable non-convertible debentures having a face value of INR 100,000 each, aggregating up to INR 12,500,000,000 (NCD Series 1); 2. 125,000 INR denominated, listed, rated, secured, redeemable, transferable non-convertible debentures having a face value of INR 100,000 each, aggregating up to INR 12,500,000,000 (NCD Series 2); and 3. 250,000 INR denominated, listed, rated, secured, redeemable, transferable non-convertible debentures having a face value of INR 100,000 each, aggregating up to INR 25,000,000,000 (NCD Series 3). The detailed disclosures in respect of NCDs is enclosed as Annexure I. 

The above information is a part of company’s filings submitted to BSE.


Mankind Pharma Share Price

2336.90 -17.50 (-0.74%)
05-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×